Pioglitazone did not reduce a composite endpoint of macrovascular complications and increased risk for heart failure in type 2 diabetes with macrovascular disease (Q82835980)
Jump to navigation
Jump to search
scientific article published on 01 March 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Pioglitazone did not reduce a composite endpoint of macrovascular complications and increased risk for heart failure in type 2 diabetes with macrovascular disease |
scientific article published on 01 March 2006 |
Statements
Pioglitazone did not reduce a composite endpoint of macrovascular complications and increased risk for heart failure in type 2 diabetes with macrovascular disease (English)